FriedLP, TangenCM, WalstonJ, NewmanAB, HirschC, GottdienerJ, Cardiovascular Health Study Collaborative Research Group, et al.: Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci56: M146–M156, 200110.1093/gerona/56.3.m146PubMed
FriedLP, TangenCM, WalstonJ, NewmanAB, HirschC, GottdienerJ, Cardiovascular Health Study Collaborative Research Group, : Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56: M146–M156, 200110.1093/gerona/56.3.m146PubMed)| false
GamboaJL, RoshanravanB, TowseT, KellerCA, FalckAM, YuC, et al.: Skeletal muscle mitochondrial dysfunction is present in patients with CKD before initiation of maintenance hemodialysis. Clin J Am Soc Nephrol15: 926–936, 202010.2215/cjn.10320819PubMed
MillerLM, RifkinD, LeeAK, Kurella TamuraM, PajewskiNM, WeinerDE, et al.: Association of urine biomarkers of kidney tubule injury and dysfunction with frailty index and cognitive function in persons with CKD in SPRINT. Am J Kidney Dis78: 530–540.e1, 202110.1053/j.ajkd.2021.01.009PubMed
MillerLM, RifkinD, LeeAK, Kurella TamuraM, PajewskiNM, WeinerDE, : Association of urine biomarkers of kidney tubule injury and dysfunction with frailty index and cognitive function in persons with CKD in SPRINT. Am J Kidney Dis 78: 530–540.e1, 202110.1053/j.ajkd.2021.01.009PubMed)| false
DalrympleLS, KatzR, RifkinDE, SiscovickD, NewmanAB, FriedLF, et al.: Kidney function and prevalent and incident frailty. Clin J Am Soc Nephrol8: 2091–2099, 201310.2215/cjn.02870313PubMed
RampersadC, DarcelJ, HarasemiwO, BrarRS, KomendaP, RigattoC, et al.: Change in physical activity and function in patients with baseline advanced nondialysis CKD. Clin J Am Soc Nephrol16: 1805–1812, 202110.2215/cjn.07050521PubMed
RampersadC, DarcelJ, HarasemiwO, BrarRS, KomendaP, RigattoC, : Change in physical activity and function in patients with baseline advanced nondialysis CKD. Clin J Am Soc Nephrol 16: 1805–1812, 202110.2215/cjn.07050521PubMed)| false
HannanM, ChenJ, HsuJ, ZhangX, SaundersMR, BrownJ, CRIC Study Investigators, et al.: Frailty and cardiovascular outcomes in adults with CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis83: 208–215, 202410.1053/j.ajkd.2023.06.009PubMed
HannanM, ChenJ, HsuJ, ZhangX, SaundersMR, BrownJ, CRIC Study Investigators, : Frailty and cardiovascular outcomes in adults with CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 83: 208–215, 202410.1053/j.ajkd.2023.06.009PubMed)| false
BrarRS, WhitlockRH, KomendaPVJ, RigattoC, PrasadB, BohmC, et al.: Provider perception of frailty is associated with dialysis decision making in patients with advanced CKD. Clin J Am Soc Nephrol16: 552–559, 202110.2215/cjn.12480720PubMed
BrarRS, WhitlockRH, KomendaPVJ, RigattoC, PrasadB, BohmC, : Provider perception of frailty is associated with dialysis decision making in patients with advanced CKD. Clin J Am Soc Nephrol 16: 552–559, 202110.2215/cjn.12480720PubMed)| false
HannaRM, GhobryL, WassefO, RheeCM, Kalantar-ZadehK: A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif49: 202–211, 202010.1159/000504240PubMed
McAdams-DeMarcoMA, IsaacsK, DarkoL, SalterML, GuptaN, KingEA, et al.: Changes in frailty after kidney transplantation. J Am Geriatr Soc63: 2152–2157, 201510.1111/jgs.13657PubMed
BeethamKS, KrishnasamyR, StantonT, SacreJW, DouglasB, IsbelNM, et al.: Effect of a 3-year lifestyle intervention in patients with chronic kidney disease: A randomized clinical trial. J Am Soc Nephrol33: 431–441, 202210.1681/asn.2021050668PubMed
WeinerDE, LiuCK, MiaoS, FieldingR, KatzelLI, GiffuniJ, et al.: Effect of long-term exercise training on physical performance and cardiorespiratory function in adults with CKD: A randomized controlled trial. Am J Kidney Dis81: 59–66, 202310.1053/j.ajkd.2022.06.008PubMed
WeinerDE, LiuCK, MiaoS, FieldingR, KatzelLI, GiffuniJ, : Effect of long-term exercise training on physical performance and cardiorespiratory function in adults with CKD: A randomized controlled trial. Am J Kidney Dis 81: 59–66, 202310.1053/j.ajkd.2022.06.008PubMed)| false
MathurV, ReavenNL, FunkSE, WhitlockR, FergusonTW, CollisterD, et al.: Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease. Clin Kidney J15: 1379–1386, 202210.1093/ckj/sfac065PubMed
MathurV, ReavenNL, FunkSE, WhitlockR, FergusonTW, CollisterD, : Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease. Clin Kidney J 15: 1379–1386, 202210.1093/ckj/sfac065PubMed)| false
NavabF, RouhaniMH, MoeinzadehF, ClarkCCT, ZiaeiR: The effects of oral sodium bicarbonate supplementation on anthropometric measures in patients with chronic kidney disease: A systematic review and meta-analysis of randomized clinical trials. Food Sci Nutr11: 6749–6760, 202310.1002/fsn3.3627PubMed
NavabF, RouhaniMH, MoeinzadehF, ClarkCCT, ZiaeiR: The effects of oral sodium bicarbonate supplementation on anthropometric measures in patients with chronic kidney disease: A systematic review and meta-analysis of randomized clinical trials. Food Sci Nutr 11: 6749–6760, 202310.1002/fsn3.3627PubMed)| false
MilneAC, PotterJ, VivantiA, AvenellA: Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev2009: Cd003288, 200910.1002/14651858.CD003288.pub3PubMed
MilneAC, PotterJ, VivantiA, AvenellA: Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009: Cd003288, 200910.1002/14651858.CD003288.pub3PubMed)| false
Cooke-HubleySM, SeniorP, BelloAK, WiebeN, KlarenbachS: Degree of albuminuria is associated with increased risk of fragility fractures independent of estimated GFR. Kidney Int Rep8: 2315–2325, 202310.1016/j.ekir.2023.08.016PubMed
Cooke-HubleySM, SeniorP, BelloAK, WiebeN, KlarenbachS: Degree of albuminuria is associated with increased risk of fragility fractures independent of estimated GFR. Kidney Int Rep 8: 2315–2325, 202310.1016/j.ekir.2023.08.016PubMed)| false
MasrouriS, EsmaeiliF, TohidiM, AziziF, HadaeghF: Rapid decline of kidney function increases fracture risk in the general population: Insights from TLGS. Bone179: 116974, 202410.1016/j.bone.2023.116974PubMed
MasrouriS, EsmaeiliF, TohidiM, AziziF, HadaeghF: Rapid decline of kidney function increases fracture risk in the general population: Insights from TLGS. Bone 179: 116974, 202410.1016/j.bone.2023.116974PubMed)| false
HsuS, BansalN, DenburgM, GinsbergC, HoofnagleAN, IsakovaT, et al.: Risk factors for hip and vertebral fractures in chronic kidney disease: The CRIC study. J Bone Miner Res39: 433–442, 202410.1093/jbmr/zjae021PubMed
HsuS, BansalN, DenburgM, GinsbergC, HoofnagleAN, IsakovaT, : Risk factors for hip and vertebral fractures in chronic kidney disease: The CRIC study. J Bone Miner Res 39: 433–442, 202410.1093/jbmr/zjae021PubMed)| false
LevyRV, McMahonDJ, AgarwalS, DempsterD, ZhouH, MisofBM, et al.: Comprehensive associations between acidosis and the skeleton in patients with kidney disease. J Am Soc Nephrol34: 668–681, 202310.1681/asn.0000000000000085PubMed
LevyRV, McMahonDJ, AgarwalS, DempsterD, ZhouH, MisofBM, : Comprehensive associations between acidosis and the skeleton in patients with kidney disease. J Am Soc Nephrol 34: 668–681, 202310.1681/asn.0000000000000085PubMed)| false
HallRK, BlumenthalJB, DoerflerRM, ChenJ, DiamantidisCJ, JaarBG, CRIC Study Investigators, et al.: Risk of potentially inappropriate medications in adults with CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis78: 837–845.e1, 202110.1053/j.ajkd.2021.03.019PubMed
MuandaFT, BlakePG, WeirMA, BathiniL, ChauvinK, DixonSN, et al.: Association of baclofen with falls and fractures in patients with CKD. Am J Kidney Dis78: 470–473, 202110.1053/j.ajkd.2020.12.017PubMed
MuandaFT, BlakePG, WeirMA, BathiniL, ChauvinK, DixonSN, : Association of baclofen with falls and fractures in patients with CKD. Am J Kidney Dis 78: 470–473, 202110.1053/j.ajkd.2020.12.017PubMed)| false
MuandaFT, WeirMA, AhmadiF, SontropJM, CowanA, FleetJL, et al.: Higher-dose gabapentinoids and the risk of adverse events in older adults with CKD: A population-based cohort study. Am J Kidney Dis80: 98–107.e1, 202210.1053/j.ajkd.2021.11.007PubMed
MuandaFT, WeirMA, AhmadiF, SontropJM, CowanA, FleetJL, : Higher-dose gabapentinoids and the risk of adverse events in older adults with CKD: A population-based cohort study. Am J Kidney Dis 80: 98–107.e1, 202210.1053/j.ajkd.2021.11.007PubMed)| false
YeungW-CG, PalmerSC, StrippoliGFM, TalbotB, ShahN, HawleyCM, et al.: Vitamin D therapy in adults with CKD: A systematic review and meta-analysis. Am J Kidney Dis82: 543–558, 202310.1053/j.ajkd.2023.04.003PubMed
YeungW-CG, PalmerSC, StrippoliGFM, TalbotB, ShahN, HawleyCM, : Vitamin D therapy in adults with CKD: A systematic review and meta-analysis. Am J Kidney Dis 82: 543–558, 202310.1053/j.ajkd.2023.04.003PubMed)| false
EvenepoelP, JørgensenHS, BoverJ, DavenportA, BacchettaJ, HaarhausM, et al.: Recommended calcium intake in adults and children with chronic kidney disease—A European consensus statement. Nephrol Dial Transplant39: 341–366, 202410.1093/ndt/gfad185PubMed
FuEL, CarreroJ-J, SangY, EvansM, IshigamiJ, InkerLA, et al.: Association of low glomerular filtration rate with adverse outcomes at older age in a large population with routinely measured cystatin C. Ann Intern Med177: 269–279, 202410.7326/m23-1138PubMed
FuEL, CarreroJ-J, SangY, EvansM, IshigamiJ, InkerLA, : Association of low glomerular filtration rate with adverse outcomes at older age in a large population with routinely measured cystatin C. Ann Intern Med 177: 269–279, 202410.7326/m23-1138PubMed)| false
IshigamiJ, SumidaK, GramsME, ChangAR, LutseyPL, LeveyAS, et al.: CKD and risk of incident hospitalization with Clostridioides difficile infection: Findings from the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis80: 297–299, 202210.1053/j.ajkd.2021.10.010PubMed
IshigamiJ, SumidaK, GramsME, ChangAR, LutseyPL, LeveyAS, : CKD and risk of incident hospitalization with Clostridioides difficile infection: Findings from the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 80: 297–299, 202210.1053/j.ajkd.2021.10.010PubMed)| false
LuczynskiP, HolmesT, RomanowskiK, ArbivOA, CookVJ, ClarkEG, et al.: Risk of tuberculosis disease in people with chronic kidney disease without kidney failure: A systematic review and meta-analysis. Clin Infect Dis77: 1194–1200, 202310.1093/cid/ciad364PubMed
LuczynskiP, HolmesT, RomanowskiK, ArbivOA, CookVJ, ClarkEG, : Risk of tuberculosis disease in people with chronic kidney disease without kidney failure: A systematic review and meta-analysis. Clin Infect Dis 77: 1194–1200, 202310.1093/cid/ciad364PubMed)| false
IshigamiJ, TaliercioJ, I FeldmanH, SrivastavaA, TownsendR, L CohenD, CRIC Study Investigators, et al.: Inflammatory markers and incidence of hospitalization with infection in chronic kidney disease. Am J Epidemiol189: 433–444, 202010.1093/aje/kwz246PubMed
IshigamiJ, TaliercioJ, I FeldmanH, SrivastavaA, TownsendR, L CohenD, CRIC Study Investigators, : Inflammatory markers and incidence of hospitalization with infection in chronic kidney disease. Am J Epidemiol 189: 433–444, 202010.1093/aje/kwz246PubMed)| false
SuG, IwagamiM, QinX, McDonaldH, LiuX, CarreroJJ, et al.: Kidney disease and mortality in patients with respiratory tract infections: A systematic review and meta-analysis. Clin Kidney J14: 602–611, 202110.1093/ckj/sfz188PubMed
IshigamiJ, CowanLT, DemmerRT, GramsME, LutseyPL, CoreshJ, et al.: Hospitalization with major infection and incidence of end-stage renal disease: The Atherosclerosis Risk in Communities (ARIC) study. Mayo Clin Proc95: 1928–1939, 202010.1016/j.mayocp.2020.02.026PubMed
IshigamiJ, CowanLT, DemmerRT, GramsME, LutseyPL, CoreshJ, : Hospitalization with major infection and incidence of end-stage renal disease: The Atherosclerosis Risk in Communities (ARIC) study. Mayo Clin Proc 95: 1928–1939, 202010.1016/j.mayocp.2020.02.026PubMed)| false
OuSM, LeeKH, TsaiMT, TsengWC, ChuYC, TarngDC: Sepsis and the risks of long-term renal adverse outcomes in patients with chronic kidney disease. Front Med (Lausanne)9: 809292, 202210.3389/fmed.2022.809292PubMed
OuSM, LeeKH, TsaiMT, TsengWC, ChuYC, TarngDC: Sepsis and the risks of long-term renal adverse outcomes in patients with chronic kidney disease. Front Med (Lausanne) 9: 809292, 202210.3389/fmed.2022.809292PubMed)| false
HamadMA, AllamH, SulaimanA, MuraliK, Cheikh HassanHI: Systematic review and meta-analysis of herpes zoster vaccine in patients with CKD. Kidney Int Rep6: 1254–1264, 202110.1016/j.ekir.2021.02.024PubMed
HamadMA, AllamH, SulaimanA, MuraliK, Cheikh HassanHI: Systematic review and meta-analysis of herpes zoster vaccine in patients with CKD. Kidney Int Rep 6: 1254–1264, 202110.1016/j.ekir.2021.02.024PubMed)| false
IshigamiJ, JaarBG, CharlestonJB, LashJP, BrownJ, ChenJ, CRIC Study Investigators, et al.: Factors associated with non-vaccination for influenza among patients with CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis83: 196–207.e1, 202410.1053/j.ajkd.2023.06.007PubMed
IshigamiJ, JaarBG, CharlestonJB, LashJP, BrownJ, ChenJ, CRIC Study Investigators, : Factors associated with non-vaccination for influenza among patients with CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 83: 196–207.e1, 202410.1053/j.ajkd.2023.06.007PubMed)| false
ScheppachJB, CoreshJ, WuA, GottesmanRF, MosleyTH, KnopmanDS, et al.: Albuminuria and estimated GFR as risk factors for dementia in midlife and older age: Findings from the ARIC study. Am J Kidney Dis76: 775–783, 202010.1053/j.ajkd.2020.03.015PubMed
ScheppachJB, CoreshJ, WuA, GottesmanRF, MosleyTH, KnopmanDS, : Albuminuria and estimated GFR as risk factors for dementia in midlife and older age: Findings from the ARIC study. Am J Kidney Dis 76: 775–783, 202010.1053/j.ajkd.2020.03.015PubMed)| false
PatersonEN, MaxwellAP, KeeF, CruiseS, YoungIS, McGuinnessB, et al.: Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA). Nephrol Dial Transplant36: 1492–1499, 202110.1093/ndt/gfab182PubMed
PatersonEN, MaxwellAP, KeeF, CruiseS, YoungIS, McGuinnessB, : Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA). Nephrol Dial Transplant 36: 1492–1499, 202110.1093/ndt/gfab182PubMed)| false
LevassortH, BoucquemontJ, Alencar de PinhoN, LambertO, HelmerC, MetzgerM, CKD-REIN Study Collaborators, et al.: A new approach for cognitive impairment pattern in chronic kidney disease. Nephrol Dial Transplant39: 848–859, 202310.1093/ndt/gfad244PubMed
LevassortH, BoucquemontJ, Alencar de PinhoN, LambertO, HelmerC, MetzgerM, CKD-REIN Study Collaborators, : A new approach for cognitive impairment pattern in chronic kidney disease. Nephrol Dial Transplant 39: 848–859, 202310.1093/ndt/gfad244PubMed)| false
BabroudiS, TighiouartH, SchraubenSJ, CohenJB, FischerMJ, RahmanM, CRIC Study Investigators, et al.: Blood pressure, incident cognitive impairment, and severity of CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis82: 443–453.e1, 202310.1053/j.ajkd.2023.03.012PubMed
LidgardB, BansalN, ZelnickLR, HoofnagleA, ChenJ, ColaizzoD, CRIC Study Investigators, et al.: Association of proximal tubular secretory clearance with long-term decline in cognitive function. J Am Soc Nephrol33: 1391–1401, 202210.1681/asn.2021111435PubMed
LidgardB, BansalN, ZelnickLR, HoofnagleA, ChenJ, ColaizzoD, CRIC Study Investigators, : Association of proximal tubular secretory clearance with long-term decline in cognitive function. J Am Soc Nephrol 33: 1391–1401, 202210.1681/asn.2021111435PubMed)| false
ChuNM, HongJ, HarasemiwO, ChenX, FowlerKJ, DasguptaI, Global Renal Exercise Network, et al.: Chronic kidney disease, physical activity and cognitive function in older adults—Results from the National Health and Nutrition Examination Survey (2011–2014). Nephrol Dial Transplant37: 2180–2189, 202210.1093/ndt/gfab338PubMed
ChuNM, HongJ, HarasemiwO, ChenX, FowlerKJ, DasguptaI, Global Renal Exercise Network, : Chronic kidney disease, physical activity and cognitive function in older adults—Results from the National Health and Nutrition Examination Survey (2011–2014). Nephrol Dial Transplant 37: 2180–2189, 202210.1093/ndt/gfab338PubMed)| false
HoJQ, VergheseJ, AbramowitzMK: Walking while talking in older adults with chronic kidney disease. Clin J Am Soc Nephrol15: 665–672, 202010.2215/cjn.12401019PubMed
ScheppachJB, WuA, GottesmanRF, MosleyTH, Arsiwala-ScheppachLT, KnopmanDS, et al.: Association of kidney function measures with signs of neurodegeneration and small vessel disease on brain magnetic resonance imaging: The Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis81: 261–269.e1, 202310.1053/j.ajkd.2022.07.013PubMed
ScheppachJB, WuA, GottesmanRF, MosleyTH, Arsiwala-ScheppachLT, KnopmanDS, : Association of kidney function measures with signs of neurodegeneration and small vessel disease on brain magnetic resonance imaging: The Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 81: 261–269.e1, 202310.1053/j.ajkd.2022.07.013PubMed)| false
LeppingRJ, MontgomeryRN, SharmaP, MahnkenJD, VidoniED, ChoiI-Y, et al.: Normalization of cerebral blood flow, neurochemicals, and white matter integrity after kidney transplantation. J Am Soc Nephrol32: 177–187, 202110.1681/asn.2020050584PubMed
BarbieriM, ChiodiniP, Di GennaroP, HafezG, LiabeufS, MalyszkoJ, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators, et al.: Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review. Pharmacol Res203: 107146, 202410.1016/j.phrs.2024.107146PubMed
BarbieriM, ChiodiniP, Di GennaroP, HafezG, LiabeufS, MalyszkoJ, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators, : Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review. Pharmacol Res 203: 107146, 202410.1016/j.phrs.2024.107146PubMed)| false
IshigamiJ, GramsME, NaikRP, CoreshJ, MatsushitaK: Chronic kidney disease and risk for gastrointestinal bleeding in the community: The Atherosclerosis Risk in Communities (ARIC) study. Clin J Am Soc Nephrol11: 1735–1743, 201610.2215/cjn.02170216PubMed
IshigamiJ, GramsME, NaikRP, CoreshJ, MatsushitaK: Chronic kidney disease and risk for gastrointestinal bleeding in the community: The Atherosclerosis Risk in Communities (ARIC) study. Clin J Am Soc Nephrol 11: 1735–1743, 201610.2215/cjn.02170216PubMed)| false
MolnarAO, BotaSE, GargAX, HarelZ, LamN, McArthurE, et al.: The risk of major hemorrhage with CKD. J Am Soc Nephrol27: 2825–2832, 201610.1681/asn.2015050535PubMed
MolnarAO, BotaSE, GargAX, HarelZ, LamN, McArthurE, : The risk of major hemorrhage with CKD. J Am Soc Nephrol 27: 2825–2832, 201610.1681/asn.2015050535PubMed)| false
FuEL, DesaiRJ, PaikJM, KimDH, ZhangY, MastrorilliJM, et al.: Comparative safety and effectiveness of warfarin or rivaroxaban versus apixaban in patients with advanced CKD and atrial fibrillation: Nationwide US cohort study. Am J Kidney Dis83: 293–305.e1, 202410.1053/j.ajkd.2023.08.017PubMed
FuEL, DesaiRJ, PaikJM, KimDH, ZhangY, MastrorilliJM, : Comparative safety and effectiveness of warfarin or rivaroxaban versus apixaban in patients with advanced CKD and atrial fibrillation: Nationwide US cohort study. Am J Kidney Dis 83: 293–305.e1, 202410.1053/j.ajkd.2023.08.017PubMed)| false
XuH, MatsushitaK, SuG, TrevisanM, ÄrnlövJ, BaranyP, et al.: Estimated glomerular filtration rate and the risk of cancer. Clin J Am Soc Nephrol14: 530–539, 201910.2215/cjn.10820918PubMed
LeesJS, ElyanBMP, HerrmannSM, LangNN, JonesRJ, MarkPB: The ‘other’ big complication: How chronic kidney disease impacts on cancer risks and outcomes. Nephrol Dial Transplant38: 1071–1079, 202310.1093/ndt/gfac011PubMed
LeesJS, ElyanBMP, HerrmannSM, LangNN, JonesRJ, MarkPB: The ‘other’ big complication: How chronic kidney disease impacts on cancer risks and outcomes. Nephrol Dial Transplant 38: 1071–1079, 202310.1093/ndt/gfac011PubMed)| false
LuoL, KienekerLM, van der VegtB, BakkerSJL, GruppenEG, CasteleijnNF, et al.: Urinary albumin excretion and cancer risk: The PREVEND cohort study. Nephrol Dial Transplant38: 2723–2732, 202310.1093/ndt/gfad107PubMed
LuoL, KienekerLM, van der VegtB, BakkerSJL, GruppenEG, CasteleijnNF, : Urinary albumin excretion and cancer risk: The PREVEND cohort study. Nephrol Dial Transplant 38: 2723–2732, 202310.1093/ndt/gfad107PubMed)| false
AuEH, WongG, HowardK, ChapmanJR, CastellsA, RogerSD, et al.: Factors associated with advanced colorectal neoplasia in patients with CKD. Am J Kidney Dis79: 549–560, 202210.1053/j.ajkd.2021.07.011PubMed
KitchluA, ReidJ, JeyakumarN, DixonSN, MunozAM, SilverSA, et al.: Cancer risk and mortality in patients with kidney disease: A population-based cohort study. Am J Kidney Dis80: 436–448.e1, 202210.1053/j.ajkd.2022.02.020PubMed
KitchluA, ReidJ, JeyakumarN, DixonSN, MunozAM, SilverSA, : Cancer risk and mortality in patients with kidney disease: A population-based cohort study. Am J Kidney Dis 80: 436–448.e1, 202210.1053/j.ajkd.2022.02.020PubMed)| false
ShemiltR, SullivanMK, HanlonP, JaniB, De La MataN, RosalesB, et al.: Sex differences in cancer outcomes across the range of eGFR. Nephrol Dial Transplant2024: gfae059, 202410.1093/ndt/gfae059PubMed
ShemiltR, SullivanMK, HanlonP, JaniB, De La MataN, RosalesB, : Sex differences in cancer outcomes across the range of eGFR. Nephrol Dial Transplant 2024: gfae059, 202410.1093/ndt/gfae059PubMed)| false
GreenDM, WangM, KrasinM, SrivastavaD, OnderS, JayDW, et al.: Kidney function after treatment for childhood cancer: A report from the St. Jude Lifetime Cohort Study. J Am Soc Nephrol32: 983–993, 202110.1681/asn.2020060849PubMed
GreenDM, WangM, KrasinM, SrivastavaD, OnderS, JayDW, : Kidney function after treatment for childhood cancer: A report from the St. Jude Lifetime Cohort Study. J Am Soc Nephrol 32: 983–993, 202110.1681/asn.2020060849PubMed)| false
LugthartG, JordansCCE, de PagterAPJ, BrestersD, Jol-van der ZijdeCM, BenseJE, et al.: Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation. Kidney Int100: 906–914, 202110.1016/j.kint.2021.05.030PubMed
LugthartG, JordansCCE, de PagterAPJ, BrestersD, Jol-van der ZijdeCM, BenseJE, : Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation. Kidney Int 100: 906–914, 202110.1016/j.kint.2021.05.030PubMed)| false